“atrial fibrillation”的搜索结果，显示 1361-1370 项，共有 7578 项

1. 妙佑医疗国际 - 视频：瓣膜保留主动脉根部置换术

   Alberto Pochettino（医学博士，妙佑医疗国际心血管外科）：我叫Alberto Pochettino，是妙佑医疗国际明尼苏达州罗切斯特院区的一名心血管外科医生。我对主动脉手术尤为 ...

2. 小儿外科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in ...

3. 三尖瓣闭锁- 医生与科室- 妙佑医疗国际

   Heart & Blood Health Discussions. damari · Taking Eliquis and Metoprolol for A-fib: Concerned about side effects. 68 Replies Wed, Apr 30, ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian ...

5. 心律不齐- 医生与科室- 妙佑医疗国际

   了解一些常见的可导致心脏跳动过快、过慢或不规则的心脏疾病。

6. 大动脉转位- 诊断与治疗- 妙佑医疗国际

   Fabre-Gray A, et al. Obstetric outcomes following atrial and arterial switch procedures for transposition of the great arteries (TGA) — A tertiary referral ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...